Profil du fabricant
Accord Healthcare Inc.
Société pharmaceutique1 produits suivis
1
produits suivis
35 777
total des notifications
54
rappels enregistrés
68,0%
graves au total
Produits
affichage de 1 sur 1
| Produit | Approuvé | Notifications ↓ | Signal principal | Rappels |
|---|---|---|---|---|
| 1995 | 35 777 | métastases osseuses | 54 |
Historique des rappels · 50 enregistrés
| Date | Classe | Motif | Fabricant |
|---|---|---|---|
| 26 janv. 2026 | II | Presence of Foreign substance - potential presence of metal particulate matter | F.H. INVESTMENTS, Inc. (dba Asteria Health) |
| 26 janv. 2026 | II | Presence of Foreign substance - potential presence of metal particulate matter | F.H. INVESTMENTS, Inc. (dba Asteria Health) |
| 26 janv. 2026 | II | Presence of Foreign substance - potential presence of metal particulate matter | F.H. INVESTMENTS, Inc. (dba Asteria Health) |
| 22 déc. 2022 | II | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. | Pharmacy Innovations |
| 23 mars 2022 | II | Lack of sterility assurance. | Drug Depot, Inc., dba APS Pharmacy |
| 23 mars 2022 | II | Lack of sterility assurance. | Drug Depot, Inc., dba APS Pharmacy |
| 7 mars 2022 | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 7 mars 2022 | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 7 mars 2022 | II | Lack of Assurance of Sterility | TMC Acquisition LLC dba Tailor Made Compounding |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 12 oct. 2021 | II | Lack of assurance of sterility | Vita Pharmacy, LLC dba Talon Compounding Pharmacy |
| 2 juil. 2020 | II | Lack of Processing Controls (lack of assurance of conformity to specifications). | MasterPharm LLC |
| 9 mai 2019 | II | GMP Deviations: Potential cross contamination due to cleaning procedure failure. | American Health Packaging |
| 9 mai 2019 | II | GMP Deviations: Potential cross contamination due to cleaning procedure failure. | American Health Packaging |
| 6 mai 2019 | II | CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. | Zydus Pharmaceuticals USA Inc |
| 6 mai 2019 | II | CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. | Zydus Pharmaceuticals USA Inc |
| 17 oct. 2018 | II | Lack of Assurance of Sterility | Qualgen, LLC |
| 22 mars 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22 mars 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22 mars 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22 mars 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22 mars 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 22 mars 2018 | II | Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. | Partell Specialty Pharmacy |
| 9 févr. 2018 | II | CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system. | American Pharmaceutical Ingredients LLC |
| 16 nov. 2017 | II | Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product. | KRS Global Biotechnology, Inc |
| 16 nov. 2017 | II | Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product. | KRS Global Biotechnology, Inc |
| 21 sept. 2016 | II | Lack of Assurance of Sterility | Wells Pharmacy Network LLC |
| 19 sept. 2016 | II | Superpotent and Subpotent drugs | Wells Pharmacy Network, LLC |
Classe I = probabilité raisonnable de préjudice grave · Classe II = temporaire ou réversible · Classe III = peu susceptible de causer un préjudice.
Statut d'enregistrement
Certains produits de Accord Healthcare Inc. ne sont pas enregistrés auprès de la FDA pour un usage humain. Pour les substances non enregistrées (peptides, SARMs sans enregistrement humain), aucun fournisseur légitime à usage humain n'existe. L'absence de filière d'approvisionnement est l'information de sécurité.